PRR32

PRR32
Identifiers
Aliases	PRR32, CXorf64, proline rich 32, chromosome x open reading frame 64, Cxorf33
External IDs	MGI: 1916050; HomoloGene: 90132; GeneCards: PRR32; OMA:PRR32 - orthologs
Gene location (Human) Chr. X chromosome (human) Band Xq25 Start 126,819,729 bp End 126,821,786 bp
Gene location (Mouse) Chr. X chromosome (mouse) Band X|X A4 Start 44,179,781 bp End 44,181,668 bp
RNA expression pattern Bgee Human Mouse (ortholog) Top expressed in right atrium right auricle body of tongue striated muscle tissue skeletal muscle tissue superior surface of tongue muscle of thigh apex of heart mucosa of nose ventricle of the heart Top expressed in Epithelium of choroid plexus choroidal fissure zygote choroid plexus of fourth ventricle secondary oocyte esophagus tongue muscle human fetus white adipose tissue primary oocyte More reference expression data BioGPS n/a
Orthologs Species Human Mouse Entrez 100130613 68800 Ensembl ENSG00000183631 ENSMUSG00000037086 UniProt B1ATL7 A2AFE9 RefSeq (mRNA) NM_001122716 NM_026841 RefSeq (protein) NP_001116188 NP_081117 Location (UCSC) Chr X: 126.82 – 126.82 Mb Chr X: 44.18 – 44.18 Mb PubMed search
Wikidata
View/Edit Human View/Edit Mouse

PRR32 is a protein that in humans is encoded by the CXorf64 (Chromosome X open reading frame 64) gene. It was also found that the homologs of the PRR32 gene is conserved in chimpanzee, Rhesus monkey, dog, cow, mouse, and rat. It was also found through ncbi that 82 organisms have orthologs with human gene PRR323.

PRR32 (CXorf64) seems to be involved with a group of genes over-expressed in ALS (Amyotrophic lateral sclerosis), evident from a study aiming to study gene expression patterns in muscles from patients with amyotrophic lateral sclerosis and multifocal motor neuropathy.

Gene

The gene is located on Chromosome X, at position Xq25, and is 2023 bases long (significantly small when compared to other genes). Its location is at the antisense ( ) strand. As shown in the graphic below, it is flanked by upstream by the DKAF12l1 shown in green on the left and downstream by LOC10. CXorf64 is the blue column shown in the middle.

Figure 1 – Genomic Context illustration for CXorf64. This segment depicts approximately 1,200,000 base pairs of chromosome 10. The green lines depict the start of transcription while the red diamonds indicate the termination of transcription. CXorf64 is transcribed in the opposite direction of its flanking genes

Transcript

CXorf64 has 1 exon which ultimately forms 1 transcript variant. This gene is expressed most in muscle tissue. There are no known isoforms in which CXorf64 is expressed.

Protein

General Properties

Property	Cleaved Protein	Mature Protein
Amino Acid Length	298	298
Isoelectric Point	7.34	~7.2-7.4
Molecular Weight	31.9 kDa	~31.9-33 kDa

Structure

Shown to the right is a predicted tertiary structure of the protein. It is marked by long alpha-helices localized to the end of the protein opposite the N- and C- terminal ends

Predicted tertiary structure of PRR32 generated by software. Based on a protein template covering 80% of the protein sequence with 96% identity.

Expression

According to microarray-assessed tissue expression analysis by NCBI GEO, the gene CXorf64 has average expression levels in most tissues save for, prostate, and heart, fat, and endometrium which have relatively low levels of expression (~25th percentile of tissue gene expression) . Almost every microarray study determined very low levels of gene expression across all tissues assessed . This evidence prompted further analysis with other tools. While no tissue analysis was present on Allen Brain Atlas or genepaint, the Human Protein Atlas suggested that the gene was more highly expressed in heart, prostate, and a and fat tissues .

NCBI Expression data. This microarray study RNA-seq was performed of tissue samples from 95 human individuals representing 27 different tissues in order to determine tissue-specificity of all protein-coding genes.

(Embryonic anterior and posterior palate). This study indicated that the posterior palate gene level expression was much higher than that of the anterior palate. Gene expression percentiles in the posterior palate averaged approximately 75th%, while in the anterior palate, gene expression was in the 25th percentile.

Sub-cellular Location

It synthesizes in the cell cytoplasm and is predicted to localize in the mitochondria. It is predicted to localize in the nucleus, plasma membrane, extracellular, mitochondrion, peroxisome, and cytosol.

Subcellular Location of PRR32.

Post-Translational Modification

N-linked glycosylation

It was found that there are several post-translational modifications that are performed on PRR32. These include several N-linked glycosylation sites that were predicted with high confidence. Glycosylation is known to play a part in cell-cell adhesion ( `a mechanism employed by cells of the immune system) via sugar-binding proteins. The graph illustrates predicted N-glyc sites across the protein chain (x-axis represents protein length from N- to C-terminal). A position with a potential (vertical lines) crossing the threshold (horizontal line at 0.5) is predicted glycosylated.

Glycosylation sites of PRR32.

Homology and Evolution

A list was generated of orthologs using the NCBI (protein) blast for PRR32, as well as UCSC’s BLAT (BLAST-Like Alignment Tool. These search and analyzing engines generated orthologs that are 80 long. This list was then narrowed down to a list of 30 different species. From those 30 species, they were divided into certain portions. The first to be selected were the primates since they are the closest related species when it comes to genetics. The similarity generated when compared to humans was approximately 95-99%. Then, using the edit and resubmit option on Blast (proteins), I excluded all primates in order to widen the species selection. The BLAST search again yielded many mammals including Rabbit, Dog, Ferret, Rhino, and many more. These species’ similarity percentage was anywhere between 69%-89%. Next, to further diversify my species selection, again using the same method, I excluded all mammals from the BLAST sequencing. This time, there were absolutely no matches in the inquiry. This action was repeated a few more times and it seems that the PRR32 gene is only relevant in mammals. The google spreadsheet created below lists the selection of species and all important information such as, order, year of divergence, etc. One thing to be noted is that the protein sequences for PRR32 were highly conserved amongst closely related species of Homo sapiens such as chimpanzees, gorillas and orangutans.

Clinical Significance

Amyotrophic lateral sclerosis

An experiment analyzed gene expression pattern in muscles from patients with amyotrophic lateral sclerosis (ALS) and multifocal motor neuropathy (MMN) compared to controls. Biopsied skeletal muscles from three ALS, three MMN and three control subjects had total RNA extracted and subjected to genome-wide gene expression analysis using Affymetrix GeneChip Exon 1.0 ST array. The most significant expression pattern differences were confirmed with RT-PCR in four additional ALS patients. Results showed that over 3000 genes were identified across the groups using q < 10%. Among 50 genes that were overexpressed only in the ALS group were: leucine-rich repeat kinase-2, follistatin, collagen type XIX alpha-1, ceramide kinase-like, sestrin-3 and CXorf64. No genes were significantly overexpressed in MMN alone. Underexpressed genes only in ALS included actinin αα3, fructose-1,6-bisphosphatase-2 and homeobox C10; whereas only in MMN: hemoglobin A1 and CXorf64. Ankyrin repeat domain-1 was overexpressed in both groups. Underexpressed genes in both groups included myosin light chain kinase-2, enolase-3 and 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-1. Validation analysis using RT-PCR confirmed the data for leucine-rich repeat kinase-2, follistatin, collagen type XIX alpha-1, ceramide kinase-like, sestrin-3 and CXorf64. In conclusion, there is differential tissue-specific gene expression in patients with ALS relative to MMN and controls. Further studies are necessary to evaluate the identified genes in larger patient groups and different tissues.